Angela M. Cacace - 13 Feb 2026 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Chief Scientific Officer
Signature
/s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace
Issuer symbol
ARVN
Transactions as of
13 Feb 2026
Net transactions value
-$54,599
Form type
4
Filing time
18 Feb 2026, 18:13:17 UTC
Previous filing
18 Jun 2025
Next filing
25 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cacace Angela M Chief Scientific Officer C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN /s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace 18 Feb 2026 0002026306

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Sale $54,599 -4,592 -2.9% $11.89 151,232 13 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on February 13, 2025. The sale does not represent a discretionary trade.
F2 Includes an aggregate of 1,576 shares of common stock of the Issuer previously purchased under and in accordance with the 2018 Employee Stock Purchase Plan of the issuer in transactions exempt under Rule 16b-3.